You are here: Home > Institute of Excellence (CPD) > CPD Events > Eye360 Footscray CPD Evening

Eye360 Footscray CPD Evening

Date: 25/08/2026 (AEST)

Venue: Vision Eye Institute 89 Paisley St, Footscray, VIC, 3011

Provider: Vision Eye Institute

Contact: Sasha Kairouz, [E] sasha.kairouz@vei.com.au, [P] 0432759015

Activity Outline

This educational evening will feature presentations from four ophthalmologists covering a range of retinal topics, including pachychoroid spectrum diseases, central serous chorioretinopathy (CSCR), secondary choroidal neovascular membranes (CNVM), medical retina, and the ocular effects of Plaquenil. The evening will conclude with an interactive trivia session focused on refractive surgery.

Learning Objectives

  • Identify the clinical features and imaging characteristics of pachychoroid spectrum diseases with a focus on central serous chorioretinopathy (CSCR) and secondary choroidal neovascular membranes (CNVM) and differentiate these conditions from other retinal pathologies.
  • Understand the ocular effects of Plaquenil (hydroxychloroquine), including current screening recommendations, risk stratification, and the role of optometrists in early detection of retinal toxicity.
  • Apply evidence-based management and co-management strategies for patients with medical retina diseases, including appropriate referral pathways and follow-up protocols.
  • Enhance knowledge of refractive surgery principles and patient suitability.

Max CPD hours awarded: 2.5

Session Information

Name
Eye360 Footscray CPD Evening
Clinical?
Yes
Interactive?
Yes
Therapeutic?
Yes
Duration of CPD Session/Module
2.5
Duration of CPD Session/Module inclusive of Assessment Component
2.5

Acknowledgement of Country

In the spirit of reconciliation Optometry Australia acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respects to their Elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.